(iii) Examining the translational value of Ppp1r1b-lncRNA manipulation requires temporal and tissue specific in vivo delivery of Ppp1r1b-lncRNA in disease models of muscular dystrophy, cardiomyopathy, and congenital heart disease. This evidence concerns the gene PPP1R1B and muscular dystrophy.